Barrington Maintains Option Care Health(OPCH.US) With Buy Rating, Maintains Target Price $38
Truist Financial Maintains Option Care Health(OPCH.US) With Buy Rating
Option Care Health Is Maintained at Outperform by Barrington Research
A Quick Look at Today's Ratings for Option Care Health(OPCH.US), With a Forecast Between $36 to $40
Analysts Offer Insights on Healthcare Companies: Option Care Health (OPCH) and HealthStream (HSTM)
Option Care Health Raised to Buy From Neutral by UBS
Option Care Health Analyst Ratings
UBS Upgrades Option Care Health to Buy, Raises Price Target to $40
Option Care Health: Strong Financial Performance and Raised Guidance Justify Buy Rating
JMP Securities Maintains Option Care Health(OPCH.US) With Buy Rating, Maintains Target Price $36
Option Care Health Price Target Maintained With a $36.00/Share by JMP Securities
Barrington Maintains Option Care Health(OPCH.US) With Buy Rating, Maintains Target Price $38
Analysts Offer Insights on Healthcare Companies: Option Care Health (OPCH), Eli Lilly & Co (LLY) and Elevance Health (ELV)
Option Care Health Analyst Ratings
Barrington Research Maintains Outperform on Option Care Health, Maintains $38 Price Target
William Blair Maintains Option Care Health(OPCH.US) With Buy Rating
William Blair Sticks to Their Buy Rating for Option Care Health (OPCH)
Jefferies Maintains Option Care Health(OPCH.US) With Buy Rating, Raises Target Price to $40
J.P. Morgan Maintains Option Care Health(OPCH.US) With Buy Rating, Raises Target Price to $41
Option Care Health Is Maintained at Overweight by JP Morgan